Rigel Pharmaceuticals, Inc.

CA · United States · Reporting entity ID 100000226808

Total reported 2019–2025

$19.8M

#319 of 2,960 reporting companies — 0% of all reported industry payments

$7.97M in general payments across 30,911 records, plus $11.9M in research funding across 552 records.

How it breaks down

General payments $7,965,916

Research funding $11,882,684

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.